Vimta Labs Limited (BOM:524394)

Market Cap	20.17B -11.8%
Revenue (ttm)	4.07B +17.9%
Net Income	775.12M +16.1%
EPS	17.20 +16.2%
Shares Out	44.67M
PE Ratio	26.25
Forward PE	n/a
Dividend	2.00 (0.44%)
Ex-Dividend Date	Jun 18, 2026

Volume	2,835
Average Volume	17,555
Open	457.20
Previous Close	450.10
Day's Range	448.05 - 457.20
52-Week Range	377.30 - 902.85
Beta	-0.18
RSI	45.35
Earnings Date	May 6, 2026

About Vimta Labs

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufactu...

• Industry: Commercial Physical and Biological Research
• Founded: 1984
• Employees: 1,315
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524394

Financial Performance

In fiscal year 2026, Vimta Labs's revenue was 4.07 billion, an increase of 17.93% compared to the previous year's 3.45 billion. Earnings were 775.12 million, an increase of 16.11%.